Go
View All
Randomised controlled trials (RCTs) of the use of long-acting injections (LAIs) in bipolar affective disorder
Rapid tranquillisation
Readiness to change, influencing adherence
Recommendations for treatment for depression in multiple sclerosis (MS)
Recommendations for treatment of psychosis in Parkinson's disease (PD)
Recommendations to patients, adherence
Recommended drugs and drugs to avoid in dementia
Recommended ECG monitoring for people taking methadone
Recommended first-line treatments for bipolar depression
Recommended monitoring for diabetes in patients receiving antipsychotic drugs
Recommended treatment strategy fo rapid-cycling bipolar disorder
Recurrent depression, prophylaxis
Reduced hepatic blood flow; consequences of hepatic impairment
Reductions of olanzapine dose by up to 5 percentage points of D2 occupancy at each step, adjusted to allow use of quarter tablets
Relapse after stopping medication
Relational aspects of adherence
Relative adverse effects
Relative frequency sexual dysfunction (SD) with antidepressants
relative infant dose (RID), medication in breastfeeding mothers
renal function, NSAIDs affecting sodium/lithium reabsorption
Reported associations between antidepressants and increased prolactin
Restarting after a break in treatment
Displaying items 1 - 30 of 72